Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study

Autor: Hui, Rina *, Özgüroğlu, Mustafa, Villegas, Augusto, Daniel, Davey, Vicente, David, Murakami, Shuji, Yokoi, Takashi, Chiappori, Alberto, Lee, Ki Hyeong, de Wit, Maike, Cho, Byoung Chul, Gray, Jhanelle E, Rydén, Anna, Viviers, Louis, Poole, Lynne, Zhang, Yiduo, Dennis, Phillip A, Antonia, Scott J
Zdroj: In The Lancet Oncology December 2019 20(12):1670-1680
Databáze: ScienceDirect